PT1042314E - Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos - Google Patents
Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidosInfo
- Publication number
- PT1042314E PT1042314E PT98962044T PT98962044T PT1042314E PT 1042314 E PT1042314 E PT 1042314E PT 98962044 T PT98962044 T PT 98962044T PT 98962044 T PT98962044 T PT 98962044T PT 1042314 E PT1042314 E PT 1042314E
- Authority
- PT
- Portugal
- Prior art keywords
- enantiomerically enriched
- oxides
- hydrobenzotiepe
- tetra
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6817097P | 1997-12-19 | 1997-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1042314E true PT1042314E (pt) | 2003-07-31 |
Family
ID=22080853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98962044T PT1042314E (pt) | 1997-12-19 | 1998-12-16 | Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6369220B1 (pt) |
| EP (1) | EP1042314B1 (pt) |
| JP (1) | JP2001526284A (pt) |
| KR (1) | KR20010015884A (pt) |
| CN (2) | CN1106395C (pt) |
| AT (1) | ATE234829T1 (pt) |
| AU (1) | AU1721399A (pt) |
| BR (1) | BR9814300A (pt) |
| DE (1) | DE69812419T2 (pt) |
| DK (1) | DK1042314T3 (pt) |
| ES (1) | ES2195428T3 (pt) |
| HK (1) | HK1034971A1 (pt) |
| HU (1) | HUP0101193A3 (pt) |
| IL (1) | IL136864A (pt) |
| PT (1) | PT1042314E (pt) |
| RU (1) | RU2236406C2 (pt) |
| UA (1) | UA67764C2 (pt) |
| WO (1) | WO1999032478A1 (pt) |
| ZA (1) | ZA9811648B (pt) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US5994391A (en) * | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| ATE242007T1 (de) | 1998-12-23 | 2003-06-15 | Searle Llc | Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen |
| AU2001240115A1 (en) * | 2000-03-10 | 2001-09-24 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| MXPA04002179A (es) | 2001-09-08 | 2004-06-29 | Astrazeneca Ab | Derivados de benzotiazepina y benzotiadiazepina con actividad inhibidora de transporte del acido ileal biliar (ibat) para tratar hiperlipidemia. |
| MXPA04003524A (es) * | 2001-11-02 | 2004-07-23 | Searle Llc | Compuestos de benzotiepina monofluorados y difluorados novedosos como inhibidores de transporte de acido biliar co-dependiente de sodio apical (asbt) y captacion de taurocolato. |
| MXPA04006255A (es) | 2002-01-17 | 2004-09-27 | Pharmacia Corp | Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato. |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| CN1930137B (zh) | 2004-02-27 | 2011-07-20 | 旭化成制药株式会社 | 苯并硫氮杂卓和苯并虑平化合物 |
| EP2367554A4 (en) | 2008-11-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | BILIARY ACID RECYCLING INHIBITORS FOR THE TREATMENT OF OBESITY AND DIABETES |
| EP2995317A1 (en) | 2010-05-26 | 2016-03-16 | Satiogen Pharmaceuticals, Inc. | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| EP3400944B1 (en) | 2010-11-04 | 2020-07-15 | Albireo AB | Ibat inhibitors for the treatment of liver diseases |
| MY180164A (en) | 2010-11-08 | 2020-11-24 | Albireo Ab | A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
| CN102558250B (zh) * | 2010-12-14 | 2015-01-14 | 王芃 | 一种艾杜糖醛酸及其衍生物的制备方法 |
| US20130108573A1 (en) | 2011-10-28 | 2013-05-02 | Lumena Pharmaceuticals, Inc. | Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease |
| SG10201909122QA (en) | 2011-10-28 | 2019-11-28 | Lumena Pharmaceuticals Inc | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases |
| BR112015023646A2 (pt) | 2013-03-15 | 2017-07-18 | Lumena Pharmaceuticals Inc | inibidores de ácidos biliares de reciclagem para tratamento de colangite esclerosante primária e doença inflamatória do intestino |
| AU2014229050A1 (en) | 2013-03-15 | 2015-10-22 | Lumena Pharmaceuticals Llc | Bile acid recycling inhibitors for treatment of Barrett's esophagus and gastroesophageal reflux disease |
| WO2014145251A1 (en) | 2013-03-15 | 2014-09-18 | Georgetown University | Determining stereoisomeric excess, concentration and absolute configuration |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| US10709755B2 (en) | 2014-06-25 | 2020-07-14 | Elobix Ab | Solid formulation and method for preventing or reducing coloration thereof |
| EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
| EP3413877B1 (en) | 2016-02-09 | 2021-04-07 | Albireo AB | Oral cholestyramine formulation and use thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| JP6954927B2 (ja) | 2016-02-09 | 2021-10-27 | アルビレオ・アクチボラグ | 経口コレスチラミン製剤及びその使用 |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| EP3664781A1 (en) | 2017-08-09 | 2020-06-17 | Albireo AB | Cholestyramine granules, oral cholestyramine formulations and use thereof |
| CA3071182A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine pellets, oral cholestyramine formulations and use thereof |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| WO2019234077A1 (en) | 2018-06-05 | 2019-12-12 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| BR112020024461A2 (pt) | 2018-06-20 | 2021-03-23 | Albireo Ab | formulação farmacêutica de odevixibat, processo para a preparação da formulação farmacêutica, e, formulação. |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| WO2020056012A1 (en) | 2018-09-11 | 2020-03-19 | Georgetown University | Quantitative auxiliary-free chirality sensing with a metal probe |
| CN109516971B (zh) * | 2018-11-26 | 2020-09-25 | 山东永浩新材料科技有限公司 | 一种电池级硫酸乙烯酯的合成方法 |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| FI3921028T3 (fi) | 2019-02-06 | 2023-01-31 | Bentsotiadiatsepiinin yhdisteet ja niiden käyttö sappihapon modulaattoreina | |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| DK3923943T3 (da) | 2019-02-12 | 2024-08-26 | Mirum Pharmaceuticals Inc | Genotype og dosisafhængig respons til en ASBTI i patienter med galdesalteksportpumpemangel |
| PE20230234A1 (es) | 2019-12-04 | 2023-02-07 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores del acido biliar |
| JP2023504647A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| CN114761018A (zh) | 2019-12-04 | 2022-07-15 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| CN116157389A (zh) | 2020-08-03 | 2023-05-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
| CN116583504A (zh) | 2020-12-04 | 2023-08-11 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| US20240116891A1 (en) * | 2022-09-14 | 2024-04-11 | Mirum Pharmaceuticals, Inc. | Maralixibat solid forms, intermediates and processes of making same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59144777A (ja) | 1983-02-04 | 1984-08-18 | Tokawa Tetsuo | ベンゾチアゼピン誘導体の光学分割法 |
| US5559017A (en) | 1989-08-09 | 1996-09-24 | E. R. Squibb & Sons, Inc. | Microbial reduction of benzazepines and benzothiazepine derivatives |
| IT1249318B (it) | 1991-05-23 | 1995-02-22 | Zambon Spa | Processo per la preparazione di benzotiazepine per ciclizzazione con acidi fosfonici |
| US5994391A (en) * | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| AU700557B2 (en) * | 1994-09-13 | 1999-01-07 | Monsanto Company | Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| CA2248586A1 (en) | 1996-03-11 | 1997-09-18 | G.D. Searle & Co. | Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
-
1998
- 1998-12-16 PT PT98962044T patent/PT1042314E/pt unknown
- 1998-12-16 DE DE69812419T patent/DE69812419T2/de not_active Expired - Fee Related
- 1998-12-16 DK DK98962044T patent/DK1042314T3/da active
- 1998-12-16 UA UA2000074377A patent/UA67764C2/uk unknown
- 1998-12-16 AU AU17213/99A patent/AU1721399A/en not_active Abandoned
- 1998-12-16 IL IL13686498A patent/IL136864A/en not_active IP Right Cessation
- 1998-12-16 BR BR9814300-0A patent/BR9814300A/pt not_active IP Right Cessation
- 1998-12-16 US US09/581,897 patent/US6369220B1/en not_active Expired - Fee Related
- 1998-12-16 JP JP2000525415A patent/JP2001526284A/ja active Pending
- 1998-12-16 WO PCT/US1998/026216 patent/WO1999032478A1/en not_active Application Discontinuation
- 1998-12-16 KR KR1020007006795A patent/KR20010015884A/ko not_active Application Discontinuation
- 1998-12-16 ES ES98962044T patent/ES2195428T3/es not_active Expired - Lifetime
- 1998-12-16 AT AT98962044T patent/ATE234829T1/de not_active IP Right Cessation
- 1998-12-16 EP EP98962044A patent/EP1042314B1/en not_active Expired - Lifetime
- 1998-12-16 HU HU0101193A patent/HUP0101193A3/hu unknown
- 1998-12-16 RU RU2000119611/04A patent/RU2236406C2/ru not_active IP Right Cessation
- 1998-12-16 CN CN98813609A patent/CN1106395C/zh not_active Expired - Fee Related
- 1998-12-18 ZA ZA9811648A patent/ZA9811648B/xx unknown
-
2001
- 2001-08-15 HK HK01105743A patent/HK1034971A1/xx not_active IP Right Cessation
-
2002
- 2002-02-11 US US10/072,600 patent/US6875877B2/en not_active Expired - Fee Related
-
2003
- 2003-02-28 CN CN03107046A patent/CN1439638A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69812419T2 (de) | 2003-08-14 |
| CN1439638A (zh) | 2003-09-03 |
| AU1721399A (en) | 1999-07-12 |
| HUP0101193A3 (en) | 2001-12-28 |
| ES2195428T3 (es) | 2003-12-01 |
| CN1284953A (zh) | 2001-02-21 |
| ATE234829T1 (de) | 2003-04-15 |
| EP1042314A1 (en) | 2000-10-11 |
| WO1999032478A1 (en) | 1999-07-01 |
| KR20010015884A (ko) | 2001-02-26 |
| EP1042314B1 (en) | 2003-03-19 |
| US20020188119A1 (en) | 2002-12-12 |
| JP2001526284A (ja) | 2001-12-18 |
| CN1106395C (zh) | 2003-04-23 |
| HUP0101193A2 (hu) | 2001-08-28 |
| US6369220B1 (en) | 2002-04-09 |
| DK1042314T3 (da) | 2003-07-14 |
| IL136864A0 (en) | 2001-06-14 |
| RU2236406C2 (ru) | 2004-09-20 |
| BR9814300A (pt) | 2002-02-05 |
| DE69812419D1 (de) | 2003-04-24 |
| IL136864A (en) | 2004-07-25 |
| UA67764C2 (uk) | 2004-07-15 |
| ZA9811648B (en) | 1999-12-20 |
| HK1034971A1 (en) | 2001-11-09 |
| US6875877B2 (en) | 2005-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1042314E (pt) | Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos | |
| DE3778343D1 (de) | Verborgene praeambel zur frequenzsprungsynchronisation. | |
| NO932870D0 (no) | Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner | |
| NO20016226D0 (no) | Fremgangsmåte for fremstilling av substituerte formamider | |
| BG102474A (en) | (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate | |
| MY116593A (en) | Process for the preparation of o-demethyltramadol enantiomers | |
| FI964739L (fi) | Menetelmä valmistaa delta9,11- ja 21-kloori-kortikosteroideja | |
| ATA1285A (de) | Verfahren zur herstellung von neuen cephalosporin-antibiotika | |
| DK0378455T3 (da) | Fremgangsmåde til fremstilling af derivater af (+)-(2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-5H-1,5-benzothiazepine-4-on | |
| DK0805806T3 (da) | Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha- | |
| IS2201B (is) | Aðferð til framleiðslu á handhverfu auðguðum N-afleiddum laktömum | |
| BR9711803A (pt) | Processo aperfei-oado para a prepara-Æo de clavulanato de pot ssio | |
| DE59611076D1 (de) | Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen | |
| ATA278885A (de) | Verfahren zur herstellung von cephalosporinderivaten | |
| KR870700627A (ko) | 세팔로스포린 유도체의 신규 제조방법 | |
| DK0796256T3 (da) | Fremgangsmåde til fremstilling af ranitidin | |
| DK0688737T3 (da) | Fremgangsmåde til fremstilling af hvidt carbon | |
| DE69529514D1 (de) | Verfahren zur herstellung von (r)-2-amino-1-phenylethanol oder seinen halogenierten derivaten, verfahren zur herstellung von optisch aktivem phenylserin und seinen halogenierten derivaten, und die neuartige verbindung 3-(3-chlorophenyl)serin | |
| DE69739392D1 (de) | Erzeugung von Sitzungsparametern für El-Gamal-ähnliche Protokolle | |
| DK0389876T3 (da) | Hidtil ukendt fremgangsmåde til syntese af N-methyl-3,4-dimethoxyphenylethylamin | |
| ATA244087A (de) | Verfahren zur herstellung von neuen cephalosporin-verbindungen | |
| CS381388A1 (en) | Method of racemic d,1-lobeline production | |
| CS381488A1 (en) | Method of racemic d,1-lobeline production | |
| DE3864286D1 (de) | Herstellungsverfahren von trifluormethylverbindungen. | |
| DK346987D0 (da) | Fremgangsmaade til fremstilling af tetrahydrofuranforbindelser |